AYOXXA Biosystems Receives Additional Series B Funds
December 03, 2014
AYOXXA Biosystems has raised an additional €2.3 million in Series B funds bringing the round total to €11.3 million; BioMedPartners and Grazia Equity provided the extra capital. The biotech research firm has developed a technology platform for multiplex protein analysis that provides the ability to analyze small samples and detect biomarkers in low concentrations. In early 2013, AYOXXA completed a €3 million Series A round.